BioSpace News Archive

DiaCarta Receives Regulatory COFEPRIS Approval in Mexico & ICMR Approval in India for its FDA EUA Approved QuantiVirus ™ SARS-CoV-2 Test

Sema4, a patient-centered health intelligence company, today announced that it has secured approval from the New York State Department of Health (NYS DOH) to conduct its Sema4 Signal™ Whole Exome/Transcriptome Sequencing (WES/WTS) and PanCancer somatic tests.

Waters Corporation (NYSE:WAT) (“Waters” or the “Company”) today announced that Udit Batra, Ph.D. has been named the Company’s President and Chief Executive Officer, effective September 1, 2020. He will also join Waters’ Board of Directors at that time. Dr. Batra succeeds Christopher O’Connell who will remain in his current roles as President and Chief Executive Offic

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced the launch of Rare Lessons, a Sarepta-led lesson planning competition intended to promote the development and implementation of educational materials to increase rare disease awareness in the K-12 classroom setting. The competition is open to educators in grades K-12, based in the United States and actively teaching in an accr

NuGenerex Immuno-Oncology, a 91% subsidiary of Generex Biotechnology Corporation (GNBT:OTCQB) announces first financing in preparation for public listing NuGenerex Immuno-Oncology is developing immunotherapeutic Ii-Key peptide vaccines for cancer and infectious diseases MIRAMAR, Fla., July 15, 2020 (GLOBE NEWSWIRE) -- NuGenerex Immuno-Oncology (NuGenerex IO), today announced the closing of a $50 Million equity financing facility to support the company’s strategic and development plans. NuG

ISM® Introduces Hospital PMI™ and Renames Non-Manufacturing Index (NMI®) as Services PMI™

Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, announced its Spiration® Valve System won Silver in the Medical category of the 2020 Edison Awards™.

Clinical Computer Systems, Inc. (CCSI), a leading provider of perinatal software, is looking forward to a successful launch of the new OBIX BeCA fetal monitor which recently obtained FDA 510(k) clearance.

The University of Pittsburgh and Vivasc Therapeutics Inc. today announced a research grant awarded by the NIH National Heart, Lung, and Blood Institute, valued at approximately $327,000 for the continued development of CTP-amio, the company’s lead compound, for the treatment of arrhythmias.

A study supported by the Alzheimer’s Drug Discovery Foundation and published today in JAMA Network Open provides the first evidence that rotigotine, a drug that acts on dopamine transmission in the brain, improves cognitive function in patients with mild-to-moderate Alzheimer’s disease.